MNKD Corp to Present at NobleCon14 - Noble Capital Markets'

[sla55]

investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=1054373

MannKind Corporation to Present at NobleCon14 - Noble Capital Markets' Fourteenth Annual Investor Conference

WESTLAKE VILLAGE, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that its Chief Executive Officer, Michael Castagna, will present at NobleCon14 — Noble Capital Markets' Fourteenth Annual Investor Conference on Monday, January 29, 2018 at 10:00 Eastern Standard Time at the W Hotel in Fort Lauderdale, Florida.

A high-definition, video webcast of the presentation will be available the following day on the Company's web site www.mannkindcorp.com, and as part of a complete catalog of presentations available at Noble Capital Markets' websites: www.noblecapitalmarkets.com, and www.nobleconference.com. You will require a Microsoft SilverLight viewer (a free download from the presentation link) to participate. The webcast and presentation will be archived on the Company's website and on the Noble websites for 90 days following the event.

ABOUT MANNKIND CORPORATION
MannKind Corporation (NASDAQ:MNKD) focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercializing Afrezza® (insulin human) inhalation powder, the Company's first FDA-approved product and the only inhaled rapid-acting mealtime insulin in the United States, where it is available by prescription from pharmacies nationwide. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. The Company also employs field sales and medical representatives across the U.S. For further information, visit www.mannkindcorp.com.

About Noble Capital Markets, Inc.
Noble Capital Markets, established in 1984, is an equity-research driven, full-service, investment & merchant banking boutique focused on the healthcare, media & entertainment, technology, transportation & logistics and natural resources sectors. The company has offices in Boca Raton, New York and Boston and St. Louis. In addition to NobleCon - the annual multi-sector investor conference - and the Media, Finance & Investor Program, produced in partnership with the National Association of Broadcasters (NAB) and held each spring in Las Vegas, throughout the year Noble hosts numerous "non-deal" corporate road shows across the United States and Canada. Members: FINRA, SIPC, MSRB. www.noblecapitalmarkets.com

[sla55]

14th Annual Institutional Investor Conference / MicroCap Showcase / January 29-30, 2018

www.nobleconference.com/agenda.htm

[cjm18]

8:15am - PANEL PRESENTATION - Studio 1 - Myth Busters: The Diabetes Debate

According to the CDC, more than 100 million U.S. adults are now living with diabetes or prediabetes. Diabetes causes more deaths per year than breast cancer and AIDS combined, yet it is among the least understood diseases we face. This esteemed panel will probe into all aspects of diabetes, from every perspective (including the patient perspective), and dispel the myths about diet, sugars and obesity. Find out about the most recent advancements in research, commercialization of therapeutic products, living with type 1 diabetes, and what to look for when considering investments. 60 minute presentation

[goyocafe]

I wonder if they'll have STAT results by then?

[digger]

Googling suggests that firm is one of the smallest brokerages in the country and has only four offices in Florida. Is presenting there really worth the cost, time, and effort?

[compound26]

It is possible that this firm may help arrange the financing for Mannkind down the road. I am not sure whether this is one of the smallest investment banks as digger's post noted. I do note that the size of the financing arranged by this firm does seem to be the type of financing Mannkind is seeking or getting.

The last several financing the firm arranged are in the following amount:

$250 million

$55 million

$72 million

$197 million 

noblecapitalmarkets.com/transactions

[boca1girl]

Jan 16, 2018 13:07:16 GMT -5 digger said:

Googling suggests that firm is one of the smallest brokerages in the country and has only four offices in Florida. Is presenting there really worth the cost, time, and effort?

Read their suggestion about who should attend.  

I hear that there is some pretty cold weather over most of the country but it is usually pretty nice in Ft. Lauderdale in late Jan.

I would attend myself but I don’t think I fit the category of “high net worth individual”, at least not yet. When MNKD gets to $40 I will be.

[peppy]

plenty of very old, money loaded people and snow birds in Florida.
January is Florida season.

florida nursing home.

[joeypotsandpans]

Jan 16, 2018 13:07:16 GMT -5 digger said:

Googling suggests that firm is one of the smallest brokerages in the country and has only four offices in Florida. Is presenting there really worth the cost, time, and effort?

So why does their website show offices in New York & Boston then? That's what came up when I went "digging", please source your link to the above referenced by you, thank you

Source: noblecapitalmarkets.com/testimonials


Contact

NOBLE CAPITAL MARKETS

BOSTON OFFICE

160 Federal Street,

21st Floor

Boston, MA 02110

T [phone]

Trading: [phone]

F: [phone]NEW YORK OFFICE

733 3rd Avenue,

16th Floor

New York, NY 10017

T:[phone]BOCA RATON OFFICE HQ

225 N.E. Mizner Boulevard

Suite 150

Boca Raton, FL 33432

T [phone]

Trading: [phone]

F: [phone]

FINRA | SIPC | MSRB | FINRA’s BROKERCHECK | PRIVACY | BUSINESS DISRUPTION | MARGIN | EXECUTION STATS | EXTENDED HOURS

[kbrion77]

Jan 16, 2018 13:07:16 GMT -5 digger said:

Googling suggests that firm is one of the smallest brokerages in the country and has only four offices in Florida. Is presenting there really worth the cost, time, and effort?

It's a small cap conference.  MNKD is a small cap.  It's honestly probably more cost effective to go to these rather than the large healthcare conferences.

[sportsrancho]

Jan 16, 2018 13:37:56 GMT -5 compound26 said:

It is possible that this firm may help arrange the financing for Mannkind down the road. I am not sure whether this is one of the smallest investment banks as digger's post noted. I do note that the size of the financing arranged by this firm does seem to be the type of financing Mannkind is seeking or getting.

The last several financing the firm arranged are in the following amount:

$250 million

$55 million

$72 million

$197 million 

noblecapitalmarkets.com/transactions

Bingo!

[compound26]

Noble also issues analyst report on biotech companies. See below: 

/

NOBLE Capital Markets research reports update October 12-20, 2017

$CRBP - Positive Top-line Phase II Data for Anabasum in Dermatomyositis

$TXMD - Assumption of Coverage with BUY Rating and $9 Price Target

$GPL - Production results similar to the last quarter and our expectations

$ASM - Marketing trip highlights growth initiatives

$AVXL - Anavex2-73 Phase 2 PK/PD Data Shows Dose-Response Effects in Measures of Cognitive Function

$AGRX - Assumption of Coverage with Buy Rating and $15 Price Target

lnkd.in/g4W_N2Y

[timri]

So what’s everyone’s gut feeling on this presentation and company. Is this just another secondary offering via atm? Or maybe they are brokering a deal between mannkind and an interested party? Or simply they are just an analysist willing to cover Mannkind and allowing them to present.

[akemp3000]

Jan 16, 2018 16:05:31 GMT -5 timri said:

So what’s everyone’s gut feeling on this presentation and company. Is this just another secondary offering via atm? Or maybe they are brokering a deal between mannkind and an interested party? Or simply they are just an analysist willing to cover Mannkind and allowing them to present.

Based on the long history of countless posts that miss speculations, it's probably best to go with "allowing them to present"...until told otherwise. That said, there's nothing wrong with hoping Locust Walk has brokered a relationship between Noble Capital and another party and that there will be...never mind

[peppy]

Jan 16, 2018 16:05:31 GMT -5 timri said:

So what’s everyone’s gut feeling on this presentation and company. Is this just another secondary offering via atm? Or maybe they are brokering a deal between mannkind and an interested party? Or simply they are just an analysist willing to cover Mannkind and allowing them to present.

MNKD looking for strong hands, buyers.
Broker's make money with sales.